ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 288

$651K Total Retail Price of All Prescriptions

Rank: 31 out of 288

426 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 636 573 1 2
SIMVASTATIN 372 345 2 1
AMLODIPINE BESYLATE 353 349 3 6
METOPROLOL TARTRATE 334 316 4 8
OMEPRAZOLE 293 270 5 3
METFORMIN HCL ER 254 241 6 76
METOPROLOL SUCCINATE 244 244 7 15
ALENDRONATE SODIUM 236 228 8 20
PRAVASTATIN SODIUM 217 179 9 21
HYDROCODONE-ACETAMINOPHEN 213 181 S3 10 7
LISINOPRIL 209 197 11 4
WARFARIN SODIUM 205 200 12 9
NAMENDA 183 183 13 39
CITALOPRAM HBR 179 150 14 18
FUROSEMIDE 174 165 15 5
HYDROCHLOROTHIAZIDE 152 150 16 13
ATENOLOL 150 150 17 10
ATORVASTATIN CALCIUM 131 130 18 14
SERTRALINE HCL 126 126 19 25
TRAMADOL HCL 118 97 20 19
DIOVAN 114 112 21 53
CELEBREX 114 95 21 84
GABAPENTIN 114 108 21 17
ZOLPIDEM TARTRATE 108 94 24 22
PREMARIN 107 105 R 25 143
PREDNISONE 105 103 26 30
DONEPEZIL HCL 103 103 27 29
ISOSORBIDE MONONITRATE ER 88 87 28 35
TAMSULOSIN HCL 87 83 29 24
CYMBALTA 87 84 29 67
LOSARTAN-HYDROCHLOROTHIAZIDE 78 78 31 55
GLIPIZIDE ER 77 72 32 93
AMITRIPTYLINE HCL 76 52 R 33 65
ZETIA 75 75 34 58
CIPROFLOXACIN HCL 73 70 35 62
LOSARTAN POTASSIUM 73 73 35 16
POTASSIUM CHLORIDE 71 69 37 11
TRIAMTERENE-HCTZ 70 70 38 28
BENAZEPRIL HCL 69 69 39 52
AMIODARONE HCL 65 65 40 137
LANTUS 61 56 41 31
CLOPIDOGREL 60 52 42 47
QUINAPRIL HCL 60 60 42 138
VENLAFAXINE HCL ER 60 36 42 94
VESICARE 59 49 45 129
CRESTOR 58 51 46 26
PLAVIX 57 52 47 71
SYNTHROID 57 57 47 63
FENTANYL 57 51 S2 47 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 45 47 34
BUPROPION XL 56 40 51 179
FOSINOPRIL SODIUM 56 56 51 166
RISPERIDONE 55 55 53 98
CLONIDINE HCL 52 52 54 70
TRICOR 52 30 54 115
ADVAIR DISKUS 51 50 56 50
METOCLOPRAMIDE HCL 51 35 56 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.